This week began for the FC Barcelona with the good news that Ansu Fati, young perl of the first staff of the team, follows improving of his injury and the terms for his turn could shorten. Like this it has informed it the same club in an official communiqué, in which it also explains that the extreme is receiving a biological treatment by part of the doctor Ramón Cugat and supervised by the doctors of the Catalan picture.

"The player of the first team Ansu Fati has done a biological treatment regenerativo by part of the doctor Ramon Cugat under the supervision of the medical services of the Club. The evolution of his injury does a course very satisfactory", went the information that the Barcelona published in the communiqué. The turn of the player would mean the enlargement of the options of attack with which explains Ronald Koeman, by what would be an extremely positive news.

It fits to remember that the young footballer of 18 years lesionó during the month of November, in the party between the Barcelona and the Betis and was diagonsticado with an injury in the internal meniscus of the left knee. Later, it was operated by the doctor Cugat, the same that it is implementing him the treatment regenerativo.

The numbers of Ansu this season

Ansu Fati, in spite of his youth, came being one of the best players of the FC Barcelona in the season, before lesionarse. In total, the precocious player had contested a total of 10 meetings, seven by LaLiga and three by the Champions League, in which it had been able to assist in two occasions and mark five goals, including one to the Real Madrid, in The Classical contested in October.

If all goes out well and the treatment to the that is being subjected Ansu Fati surte the effect wished, the player could go back before the expected to the terrains of game. Although there are not speculative dates still, expects that all give so that the extreme youngster was earlier that late ofturn , contributing the quota of goals and vertigo to which has accustomed to the surroundings cule.